Subscribe to our mailing list

Get regular updates delivered to your email box.
Thank you for subscribing!

Spinraza Approved for All Types of Spinal Muscular Atrophy in Europe


In their most recent podcast, the team at Muscle Owl talk about the latest Spinraza news. The European Medical Agency (EMA) has approved the use of Spinraza for all types of spinal muscular atrophy (SMA), so individual countries can now begin the process of approving the drug for treatment.

MORE: EMA panel recommends approval of Spinraza in Europe.

The approval comes on the heels of phase 3 clinical trial results, which showed that Spinraza can significantly improve muscle function and motor skills in children with type 2 SMA. The news may make insurance companies more willing to pay for the treatment for adults and older children who have type 2 and type 3 SMA. Find out more about this trial here. 

MORE: Nine commonly asked questions about Spinraza.

SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?


  1. turgut says:

    Price is so high and i think it is dangerous because of late results. In the official news of spinraza firm it was only beneficial 40 percent sma patients. It not is logical to involve for type 2 sma. Gene replacement method will be applied in type 2 sma. Spinzara firm makes hurry people because of gene replecement coming.

Leave a Comment

Your email address will not be published. Required fields are marked *